PMID- 38252153 OWN - NLM STAT- MEDLINE DCOM- 20240205 LR - 20240205 IS - 1420-9071 (Electronic) IS - 1420-682X (Print) IS - 1420-682X (Linking) VI - 81 IP - 1 DP - 2024 Jan 22 TI - Combination of blockade of endothelin signalling and compensation of IGF1 expression protects the retina from degeneration. PG - 51 LID - 10.1007/s00018-023-05087-x [doi] LID - 51 AB - Retinitis pigmentosa (RP) and macular dystrophy (MD) cause severe retinal dysfunction, affecting 1 in 4000 people worldwide. This disease is currently assumed to be intractable, because effective therapeutic methods have not been established, regardless of genetic or sporadic traits. Here, we examined a RP mouse model in which the Prominin-1 (Prom1) gene was deficient and investigated the molecular events occurring at the outset of retinal dysfunction. We extracted the Prom1-deficient retina subjected to light exposure for a short time, conducted single-cell expression profiling, and compared the gene expression with and without stimuli. We identified the cells and genes whose expression levels change directly in response to light stimuli. Among the genes altered by light stimulation, Igf1 was decreased in rod photoreceptor cells and astrocytes under the light-stimulated condition. Consistently, the insulin-like growth factor (IGF) signal was weakened in light-stimulated photoreceptor cells. The recovery of Igf1 expression with the adeno-associated virus (AAV) prevented photoreceptor cell death, and its treatment in combination with the endothelin receptor antagonist led to the blockade of abnormal glial activation and the promotion of glycolysis, thereby resulting in the improvement of retinal functions, as assayed by electroretinography. We additionally demonstrated that the attenuation of mammalian/mechanistic target of rapamycin (mTOR), which mediates IGF signalling, leads to complications in maintaining retinal homeostasis. Together, we propose that combinatorial manipulation of distinct mechanisms is useful for the maintenance of the retinal condition. CI - (c) 2024. The Author(s). FAU - Shigesada, Naoya AU - Shigesada N AD - Division of Biological Science, Nara Institute of Science and Technology, Ikoma, 630-0192, Japan. FAU - Shikada, Naoya AU - Shikada N AD - Division of Biological Science, Nara Institute of Science and Technology, Ikoma, 630-0192, Japan. FAU - Shirai, Manabu AU - Shirai M AD - Omics Research Center (ORC), National Cerebral and Cardiovascular Center, Suita, Osaka, 564-8565, Japan. FAU - Toriyama, Michinori AU - Toriyama M AD - Department of Biomedical Chemistry, School of Science and Technology, Kwansei Gakuin University, Sanda, 669-1337, Japan. FAU - Higashijima, Fumiaki AU - Higashijima F AD - Department of Ophthalmology, Graduate School of Medicine, Yamaguchi University, Ube, 755-0046, Japan. FAU - Kimura, Kazuhiro AU - Kimura K AD - Department of Ophthalmology, Graduate School of Medicine, Yamaguchi University, Ube, 755-0046, Japan. FAU - Kondo, Toru AU - Kondo T AD - Division of Stem Cell Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo, 060-0815, Japan. FAU - Bessho, Yasumasa AU - Bessho Y AD - Division of Biological Science, Nara Institute of Science and Technology, Ikoma, 630-0192, Japan. FAU - Shinozuka, Takuma AU - Shinozuka T AD - Division of Biological Science, Nara Institute of Science and Technology, Ikoma, 630-0192, Japan. FAU - Sasai, Noriaki AU - Sasai N AUID- ORCID: 0000-0003-0360-1138 AD - Division of Biological Science, Nara Institute of Science and Technology, Ikoma, 630-0192, Japan. noriakisasai@bs.naist.jp. LA - eng GR - 21H02886/Japan Society for the Promotion of Science/ GR - 23H02677/Japan Society for the Promotion of Science/ GR - 23K14196/Japan Society for the Promotion of Science/ GR - 20H03263/Japan Society for the Promotion of Science/ GR - 20H05036/Japan Society for the Promotion of Science/ PT - Journal Article DEP - 20240122 PL - Switzerland TA - Cell Mol Life Sci JT - Cellular and molecular life sciences : CMLS JID - 9705402 RN - 0 (Endothelins) RN - 67763-96-6 (Insulin-Like Growth Factor I) RN - 0 (insulin-like growth factor-1, mouse) SB - IM MH - Animals MH - Mice MH - Endothelins MH - Insulin-Like Growth Factor I/genetics MH - *Macular Degeneration MH - Retina MH - *Retinal Diseases MH - Retinal Rod Photoreceptor Cells MH - *Retinitis Pigmentosa PMC - PMC10803390 OTO - NOTNLM OT - Adeno-associated virus (AAV) OT - Gliosis OT - Insulin-like growth factor (IGF) OT - Mammalian/mechanical target of rapamycin (mTOR) OT - Prominin-1 OT - Retinitis pigmentosa OT - Single-cell RNA sequencing (scRNA-seq) COIS- The authors declare that no competing interests exist. EDAT- 2024/01/22 12:42 MHDA- 2024/01/23 06:43 PMCR- 2024/01/22 CRDT- 2024/01/22 11:05 PHST- 2023/07/22 00:00 [received] PHST- 2023/12/12 00:00 [accepted] PHST- 2023/12/01 00:00 [revised] PHST- 2024/01/23 06:43 [medline] PHST- 2024/01/22 12:42 [pubmed] PHST- 2024/01/22 11:05 [entrez] PHST- 2024/01/22 00:00 [pmc-release] AID - 10.1007/s00018-023-05087-x [pii] AID - 5087 [pii] AID - 10.1007/s00018-023-05087-x [doi] PST - epublish SO - Cell Mol Life Sci. 2024 Jan 22;81(1):51. doi: 10.1007/s00018-023-05087-x.